Provenance
Created by SPS, NHS England, the Royal College of Radiologists (RCR) and the Society of Radiographers (SoR), with the support of specialists working within clinical practice, for contrast agents commonly used in NHS England-commissioned radiology services.
PGD template attachment
This attached template covers the following gadoteric acid meglumine contrast agents:
- Dotarem®
- Clariscan®
- Dotagraf®
- Cyclolux®
Download and use in conjunction with our implementation advice.
Version 3.0 published
Version 3.0 of this PGD template has been published and is valid for use from April 2025. It has been published in advance of its valid from date to allow organisations time to take it through local governance processes.
Version 2.0 remains valid until the end of March 2025 – it will be removed from this webpage on expiry.
More radiology PGD templates
- Gadopiclenol contrast agent
- Sodium chloride 0.9% in multi injector devices
- Ioversol contrast agent
- Gadoxetate disodium contrast agent
- Gadoteridol contrast agent
- Gadobenate dimeglumine contrast agent
- Gadobutrol contrast agent
- Iodixanol contrast agent
- Iohexol contrast agent
- Iopamidol contrast agent
- Iomeprol contrast agent
All PGD templates
Templates
Update history
- V3 published
- Title, URL and summary amended.
- Temporary detail on expiry of V1.0 removed
- V2.1 uploaded (rewording of adverse effects section)
- Updated PGD template V2.0 added
- Published